van Berkel TJ - Search Results

1

Hepatic glycosphingolipid deficiency and liver function in mice.

Jennemann R, Rothermel U, Wang S, Sandhoff R, Kaden S, Out R, van Berkel TJ, Aerts JM, Ghauharali K, Sticht C, Gröne HJ. Jennemann R, et al. Among authors: van berkel tj. Hepatology. 2010 May;51(5):1799-809. doi: 10.1002/hep.23545. Hepatology. 2010. PMID: 20432257

2

Liver X receptors inhibit macrophage proliferation through downregulation of cyclins D1 and B1 and cyclin-dependent kinases 2 and 4.

Pascual-García M, Carbó JM, León T, Matalonga J, Out R, Van Berkel T, Sarrias MR, Lozano F, Celada A, Valledor AF. Pascual-García M, et al. J Immunol. 2011 Apr 15;186(8):4656-67. doi: 10.4049/jimmunol.1000585. Epub 2011 Mar 11. J Immunol. 2011. PMID: 21398609

3

Lack of Abcg1 results in decreased plasma HDL cholesterol levels and increased biliary cholesterol secretion in mice fed a high cholesterol diet.

Wiersma H, Nijstad N, de Boer JF, Out R, Hogewerf W, Van Berkel TJ, Kuipers F, Tietge UJ. Wiersma H, et al. Among authors: van berkel tj. Atherosclerosis. 2009 Sep;206(1):141-7. doi: 10.1016/j.atherosclerosis.2009.02.022. Epub 2009 Mar 11. Atherosclerosis. 2009. PMID: 19339012

4

Human ATP-binding cassette G1 controls macrophage lipoprotein lipase bioavailability and promotes foam cell formation.

Olivier M, Tanck MW, Out R, Villard EF, Lammers B, Bouchareychas L, Frisdal E, Superville A, Van Berkel T, Kastelein JJ, Eck MV, Jukema JW, Chapman MJ, Dallinga-Thie GM, Guerin M, Le Goff W. Olivier M, et al. Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2223-31. doi: 10.1161/ATVBAHA.111.243519. Epub 2012 Jul 5. Arterioscler Thromb Vasc Biol. 2012. PMID: 22772754

5

Selective hepatic drug delivery: from basic concept to clinical practice.

Van Berkel TJ. Van Berkel TJ. Hepatology. 1997 Dec;26(6):1680-1. doi: 10.1002/hep.510260644. Hepatology. 1997. PMID: 9398016 No abstract available.

6

Emerging roles of the intestine in control of cholesterol metabolism.

Kruit JK, Groen AK, van Berkel TJ, Kuipers F. Kruit JK, et al. Among authors: van berkel tj. World J Gastroenterol. 2006 Oct 28;12(40):6429-39. doi: 10.3748/wjg.v12.i40.6429. World J Gastroenterol. 2006. PMID: 17072974 Free PMC article. Review.

7

FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice.

Nofer JR, Bot M, Brodde M, Taylor PJ, Salm P, Brinkmann V, van Berkel T, Assmann G, Biessen EA. Nofer JR, et al. Circulation. 2007 Jan 30;115(4):501-8. doi: 10.1161/CIRCULATIONAHA.106.641407. Epub 2007 Jan 22. Circulation. 2007. PMID: 17242282

8

Galactose-specific asialoglycoprotein receptor is involved in lipoprotein (a) catabolism.

Hrzenjak A, Frank S, Wo X, Zhou Y, Van Berkel T, Kostner GM. Hrzenjak A, et al. Biochem J. 2003 Dec 15;376(Pt 3):765-71. doi: 10.1042/BJ20030932. Biochem J. 2003. PMID: 14510638 Free PMC article.

9

Lipid emulsions potently increase transgene expression in hepatocytes after adenoviral transfer.

Snoeys J, Mertens G, Lievens J, van Berkel T, Collen D, Biessen EA, De Geest B. Snoeys J, et al. Mol Ther. 2006 Jan;13(1):98-107. doi: 10.1016/j.ymthe.2005.06.477. Epub 2005 Aug 19. Mol Ther. 2006. PMID: 16112619 Free article.

10

CCL18 aggravates atherosclerosis by inducing CCR6-dependent T-cell influx and polarization.

Singh A, Kraaijeveld AO, Curaj A, Wichapong K, Hammerich L, de Jager SCA, Bot I, Atamas SP, van Berkel TJC, Jukema JW, Comerford I, McColl SR, Mees B, Heemskerk JWM, Nicolaes GAF, Hackeng T, Liehn EA, Tacke F, Biessen EAL. Singh A, et al. Among authors: van berkel tjc. Front Immunol. 2024 May 13;15:1327051. doi: 10.3389/fimmu.2024.1327051. eCollection 2024. Front Immunol. 2024. PMID: 38807599 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

448 results

Search Page